BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 13, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 22, 2014
View Archived Issues
Structure-based discovery of novel ITK inhibitors, GNE-9822 lead identified
Read More
A potent mGluR5 PAM shows promise in rodent cognition models
Read More
Results of a phase I dose-escalation study of a chikungunya virus vaccine
Read More
VX-787, first-in-class PB2 influenza polymerase inhibitor
Read More
arGEN-X reports preclinical data for ARGX-113
Read More
Glenmark Pharmaceuticals to begin IND-enabling studies of new bispecific antibody
Read More
Bristol-Myers Squibb and Celgene to evaluate immunotherapy/chemotherapy combination
Read More
Amicus Therapeutics reports phase III data for migalastat in Fabry disease
Read More
Pfizer and Crohn's & Colitis Foundation of America form IBD collaboration
Read More
Aeolus files IND for acute radiation syndrome candidate AEOL-10150
Read More
Illumina forms multiple collaborations for oncology genomics analysis
Read More
AM-9514, a GK activator with good pharmacokinetic profile in vivo
Read More
KalVista Pharmaceuticals confirms first-in-human trial of KVD-001
Read More
Potential AD treatment activates TGF-beta signaling pathway in the brain
Read More
Vertex Pharmaceuticals patents novel sodium channel blockers
Read More
Toyama designs novel antifungal agents
Read More
Researchers at Bayer Schering Pharma synthesize new products for cancer
Read More
Hanmi Pharm enters into agreement with Luye Pharma Group for poziotinib
Read More
Korean scientists present new anti-C5 MAbs
Read More
ViaCyte and Janssen enter rights agreement for type 1 diabetes cell therapy
Read More
Baxter's PEGylated rFVIII meets primary endpoint in phase III trial
Read More
Apixaban granted FDA approval for DVT and PE
Read More
EMA accepts Basilea Pharmaceutica's isavuconazole MAA for review
Read More
Lilly's ixekizumab superior to etanercept in phase III plaque psoriasis trials
Read More
Auxilium and BioSpecifics report positive data from phase IIa trial of Xiaflex
Read More
GSK to conduct phase II study of GSK-2862277 to prevent acute lung injury
Read More